29
Participants
Start Date
June 30, 2010
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
Guanfacine extended-release tablets
Guanfacine extended-release tablets will be started at 1mg and then increased at weekly intervals to 2mg, 3mg, or 4mg as needed and as tolerated
Placebo comparator
Placebo tablets identical to the experimental arm guanfacine extended-release tablets 1mg, 2mg, 3mg, 4mg, but without the active ingredient (guanfacine).
Children's Specialized Hospital, Hamilton
Children's Specialized Hospital, Toms River
Collaborators (1)
Shire
INDUSTRY
Children's Specialized Hospital
OTHER